Syros Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
13 Oct 2022	Form 3: Quirk Gerald E, Chief Legal Officer Holds 8,700 shares of Common Stock
19 Sep 2022	Form 3: Tyson Timothy, Director No securities owned
19 Sep 2022	Form 3: Oh Andrew M., Director No securities owned
13 Oct 2021	Form 3: Haas Jason, Chief Financial Officer No securities owned
28 Sep 2021	Form 3: Chee Conley, Chief Commercial Officer No securities owned
10 Sep 2021	Form 3: Dunsire Deborah, Director No securities owned
10 Jun 2021	Form 3: Stephens Kristin, Chief Development Officer Holds 45,000 shares of Common Stock
09 Sep 2020	Form 3: Eckhardt Sue Gail, Director No securities owned
20 Dec 2019	Form 3: Alles Mark J, Director No securities owned
12 Jun 2019	Form 3: Shaw Alice Tsang, Director No securities owned
15 Jun 2018	Form 3: Bonney Michael W, Director
12 Mar 2018	Form 3: Ferra Joseph J Jr, Chief Financial Officer No securities owned
14 Nov 2017	Form 3: Springhorn Jeremy P., Chief Business Officer No securities owned
06 Oct 2017	Form 3: DeSimone Colleen Elizabeth, Principal Accounting Officer
12 Jun 2017	Form 3: Akkaraju Srinivas, Director Holds 720,720 shares of Common Stock
30 Jan 2017	Form 3: Wirth Peter, Director No securities owned
29 Sep 2016	Form 3: Quirk Gerald E, Chief Legal Officer No securities owned
29 Jun 2016	Form 3: Redmile Group, Llc, 10% owner and 1 other
29 Jun 2016	Form 3: WuXi Healthcare Ventures II, L.p., 10% owner
29 Jun 2016	Form 3: Jeb Syros Trust, 10% owner Holds 351,666 shares of Common Stock

Comments